- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02736331
Different Types of Fruits on Metabolic Function and Cognitive Performance (WBB2)
The Effect of Different Types of Fruits on Metabolic Function and Cognitive Performance
Primary objective is to assess the effect of the intake of different types of fruits on memory and attention.
Secondary objective is to assess effect of intake of different types of fruits on metabolic markers, including glucose, insulin, total cholesterol and triglyceride and the pharmacokinetic profile of the anthocyanins.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
The trial is designed as a randomized 2-arm, placebo-controlled, within-subjects crossover utilizing a multiple sampling, repeated measures paradigm to investigate the effects of consumption of different types of fruits on cognitive performance and metabolic responses. This trial will test 2 treatment conditions in forty men and women who will be enrolled into the study.
Each subject will be asked to come for one screening visit, a pre-study visit, and two dinner pick-ups the day before each of the two test visits and 2 test visits. Participation in this study will last approximately four weeks.
The initial screening visit will provide the subject with the informed consent document and determine eligibility through anthropometric measurements, vital signs, fasting blood glucose test , vein assessment, color test and completion of a survey relate to general eating, health, and exercise habits. In addition, subjects will take brief tests of attention and memory to ensure capability and willingness to perform tests during subsequent research visits. Eligible subjects will be trained and instructed to record all food and beverages consumed for a 3-day period (one weekend day and two weekdays) on food record diaries. At the pre-study visit, subjects will be instructed to follow a strictly limited polyphenolic diet for 7 days prior to the study and throughout their participation time, while maintaining their usual diet pattern and physical activity. A dinner meal will be provided the day before the study visit.
At each test visit, subjects will arrive at the clinic after fasting 8 to 12 hours and in a well-hydrated state. After confirming compliance with protocol, anthropometric measurements and vital signs will be taken along with a finger prick for fasting blood glucose and a catheter placement .
Fasting baseline blood sample from a catheter will be collected after which baseline cognitive performance measures will be assessed. After completing baseline measures, subjects will receive a standard breakfast meal along with a beverage containing different fruits according to the randomization sequence. Additional blood samples will be taken at 30, 60, 120, 180, 240, 300, 360, and 480 minutes after the start of the breakfast meal. Additional cognitive tests will be performed at the 120, 240, 360, and 480 minute time points. A standardized lunch will be provided between the 360 and 480 minute time points.
Subject will come to the clinic for 2 test day visits; all procedures will be the same except for the treatment (the test or control treatment).
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Illinois
-
Chicago, Illinois, Verenigde Staten, 60616
- Clinical Nutrition Research Center
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
• Subject is male or female aged between 40 and 65 years of age
- Subject has BMI between 18.5 and 34.9 kg/m2, (inclusive) at screening visit
- Fasting blood sugar less than 126 mg/dL
- Average Blood pressure less than 160/100 mmHg
- Subject is willing to maintain a stable body weight and to follow his/her regular diet and physical activity patterns throughout the study period.
- Subject is willing to refrain from vigorous physical activity and consumption of alcoholic and/or caffeinated beverages 24 h prior to each test day
- Subject does not smoke or has abstained from smoking for at least 2 years
- No clinical evidence of cardiovascular, metabolic, respiratory, renal, gastrointestinal or hepatic disease
- Not taking any medications or dietary supplements that would interfere with outcomes of the study.
Exclusion Criteria:
• Subject currently smokes or has smoked within the past 2 years
- Subject works overnight i.e. the night shift
- Subjects who have a significant sleep disorder, a traumatic brain injury, have a learning disability or attention deficit disorder or any psychiatric or neurological disturbances
- Subject is color blind, has impaired cognitive performance on the flanker test (score <60 at screening) or has a vein access score <7
- Men and women with known or suspected food intolerance, allergies or hypersensitivity to the study materials or closely related compounds
- Men and women known to have/diagnosed with diabetes mellitus
- Men and women with a fasting blood glucose concentration ≥126 mg/dL
- Average blood pressure > 160/100 mmHg during screening visit
- Men and women with documented vascular disease, e.g., heart failure, myocardial infarction, stroke, angina, related surgeries
- Men and women with cancer other than non-melanoma skin cancer in previous 2 years
- Men and women who are taking medication or dietary supplements that may interfere with the study procedures or the endpoints of the study (e.g. antioxidants, anti-inflammatory medications, antidepressant medications, oral and injectable hypoglycemic medications, GI medications, antibiotics, diuretics, adrenergic blockers etc.) Subjects may choose to go off dietary supplements (requires 30 days washout)
- Men and women taking antibiotics within 5 days of study start
- Men and women who have donated blood/plasma within 3 months of the screening visit and blood donors/participants for whom participation in this study will result in having donated more than 1500 milliliters of blood in the previous 12 months
- Substance (alcohol or drug) abuse within the last 2 years
- Excessive coffee and tea consumption (> 4 cups/day)
- Unstable body weight fluctuations of >4.5kg (9.9lbs) in the past 4 weeks
- Women who are known to be pregnant or who are intending to become pregnant over the course of the study and women who are lactating.
- Men and women whom investigator is uncertain about subject's capability or willingness to comply with protocol requirements
- Women who are taking unstable dose and brand of hormonal contraceptives and/or stable dose and brand less than 6 months.
- Men and women who do excessive exercise regularly or are athlete
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Fundamentele wetenschap
- Toewijzing: Gerandomiseerd
- Interventioneel model: Crossover-opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Treatment 1 Beverage
Treatment 1
|
Treatment 1 Beverage
|
|
Placebo-vergelijker: Treatment 2 Beverage
Treatment 2
|
Treatment 2 Beverage
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Changes in memory function using the Montreal Cognitive Assessment after intake of different types of fruits
Tijdsspanne: 8 hours Postprandial Study
|
Sum all sub-scores of the Montreal Cognitive Assessment
|
8 hours Postprandial Study
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Changes in plasma glucose concentrations after intake of different types of fruits
Tijdsspanne: 8 hours Postprandial Study
|
plasma glucose concentrations after intake of different types of fruits
|
8 hours Postprandial Study
|
|
Changes in plasma insulin concentrations after intake of different types of fruits
Tijdsspanne: 8 hours Postprandial Study
|
insulin concentrations after intake of different types of fruits
|
8 hours Postprandial Study
|
|
Changes in plasma Triglycerides Concentrations after intake of different types of fruits
Tijdsspanne: 8 hours Postprandial Study
|
Plasma Triglycerides Concentrations after intake of different types of fruits
|
8 hours Postprandial Study
|
|
Changes in plasma Total Cholesterol Concentrations after intake of different types of fruits
Tijdsspanne: 8 hours Postprandial Study
|
plasma Total Cholesterol Concentrations after intake of different types of fruits
|
8 hours Postprandial Study
|
Andere uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Changes in polyphenol anthocyanin concentrations after intake of different types of fruits
Tijdsspanne: 8 hours Postprandial Study
|
polyphenol anthocyanin concentrations after intake of different types of fruits
|
8 hours Postprandial Study
|
|
Changes in LDL oxidation after intake of different types of fruits
Tijdsspanne: 8 hours Postprandial Study
|
OxLDL after intake of different types of fruits
|
8 hours Postprandial Study
|
|
Changes in IL-6 after intake of different types of fruits
Tijdsspanne: 8 hours Postprandial Study
|
IL-6 after intake of different types of fruits
|
8 hours Postprandial Study
|
|
Changes in IL-1beta after intake of different types of fruits
Tijdsspanne: 8 hours Postprandial Study
|
IL-1beta after intake of different types of fruits
|
8 hours Postprandial Study
|
|
Changes in IL-10 after intake of different types of fruits
Tijdsspanne: 8 hours Postprandial Study
|
IL-10 after intake of different types of fruits
|
8 hours Postprandial Study
|
|
Changes in MCP-1 after intake of different types of fruits
Tijdsspanne: 8 hours Postprandial Study
|
MCP-1 after intake of different types of fruits
|
8 hours Postprandial Study
|
Medewerkers en onderzoekers
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- IRB2015-105
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Gezond
-
University Hospital, GhentWervingHealthy Controls Group - Leeftijd en geslacht afgestemd | Herhaaldelijk negatief denkenBelgië
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteWervingHealthy Controls Group - Leeftijd en geslacht afgestemd | Borderline persoonlijkheidsstoornis (BPS)Verenigde Staten
-
Hacettepe UniversityWervingBronchiëctasie Volwassene | Healthy Controls Group - Leeftijd en geslacht afgestemdKalkoen
-
Hasselt UniversityWervingMultiple sclerose | Healthy Controls Group - Leeftijd en geslacht afgestemdBelgië, Italië, Spanje
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Brain and Behavior...WervingOpioïdengebruiksstoornis | Healthy Controls Group - Leeftijd en geslacht afgestemdVerenigde Staten
-
University of LeicesterNational Institute for Health Research, United KingdomVoltooidPatiënten met hartfalen en behouden ejectiefractie - HFpEF | Patiënten met hartfalen met verminderde ejectiefractie - HFrEF | Healthy Controls Group - Leeftijd en geslacht afgestemd
-
University of North Carolina, Chapel HillNational Institute of Neurological Disorders and Stroke (NINDS)WervingMusculoskeletale pijn | Fibromyalgie | Healthy Controls Group - Leeftijd en geslacht afgestemdVerenigde Staten
-
Gulseren Demir KarakilicVoltooidFibromyalgie Syndroom | Healthy Controls Group - Leeftijd en geslacht afgestemdKalkoen
-
University Hospital, GrenobleUniversity Hospital, Clermont-Ferrand; Grenoble Institut des NeurosciencesBeëindigdZiekte van Parkinson | Healthy Controls Group - Leeftijd en geslacht afgestemdFrankrijk
-
Abant Izzet Baysal UniversityVoltooidHealthy Controls Group - Leeftijd en geslacht afgestemd | Ziekte van Alzheimer (AD)Turkije (Türkiye)
Klinische onderzoeken op Treatment 1
-
Revision SkincareVoltooidHyperpigmentatie | Ruwheid van de huid | Post-inflammatoire hyperpigmentatie | HuidverouderingVerenigde Staten
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceWervingActieve kanker en symptomatische of incidentele longembolie zonder HESTIA-criteriaFrankrijk
-
Karolinska InstitutetEvira ABVoltooidAnorexia nervosa | Boulimia nervosa | Obesitas bij kinderen | Vreetbui syndroom | Ongeordend etenZweden
-
Johns Hopkins Bloomberg School of Public HealthUnited States Agency for International Development (USAID)VoltooidDepressie | Post-traumatische stress-stoornisOekraïne
-
Tel Aviv UniversityVoltooidAttention Bias Modification Treatment (ABMT)Israël
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...WervingChronische migraine; Multiple sclerose; Motoneuron ziekteItalië
-
University of Illinois at ChicagoNational Institute on Minority Health and Health Disparities (NIMHD); Sinai Urban...Nog niet aan het wervenDepressie | Ongerustheid | Traumatische stress
-
Stanford UniversityBeëindigdAutisme Spectrum Stoornis | AutismeVerenigde Staten
-
Chang Gung Memorial HospitalMinistry of Science and Technology, TaiwanVoltooid
-
Institute for Clinical Effectiveness and Health...University of WashingtonActief, niet wervendTuberculose | TherapietrouwArgentinië